MYCL and small cell lung carcinoma: Furthermore, MYC status has been attributed to phenotypic diversity of SCLCs, with MYCL- and MYC-driven SCLC cell lines differing in numerous aspects from transcriptional signatures, super enhancer usage, metabolic regulation, and therapeutic response (Ireland et al., 2020).